| Longitude Capital Partners Iv, Llc |
Non-Executive |
Lexeo Therapeutics, Inc. (LXEO)
|
2023-11-07 |
$11.00 |
3.6% |
454,545
|
$4,999,995 |
| Longitude Capital Partners Iv, Llc |
Non-Executive |
Vera Therapeutics, Inc. (VERA)
|
2023-02-06 |
$7.00 |
445.1% |
1,714,285
|
$11,999,995 |
| Longitude Capital Partners Iv, Llc |
Non-Executive |
Vera Therapeutics, Inc. (VERA)
|
2022-02-10 |
$15.00 |
154.4% |
333,333
|
$4,999,995 |
| Longitude Capital Partners Iv, Llc |
Non-Executive |
Vera Therapeutics, Inc. (VERA)
|
2021-05-18 |
$11.00 |
246.9% |
909,090
|
$9,999,990 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
268.8% |
$86,009,815 |
$31,999,975 |